| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |